Banks (Finance)
Belite Bio to Present at dbVIC - Deutsche Bank ADR Virtual Investor Conference
Belite Bio, a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases, announced that Hao-Yuan Chuang, Chief Financial Officer, will present live at the dbVIC - Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference hosted by VirtualInvestorConferences.com. The conference is aimed at introducing global